Clinical Trials Directory

Trials / Completed

CompletedNCT00150423

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
384 (planned)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and efficacy of pregabalin in patients with painful diabetic peripheral neuropathy.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin

Timeline

Start date
2001-01-01
Completion
2005-07-01
First posted
2005-09-08
Last updated
2007-01-01

Source: ClinicalTrials.gov record NCT00150423. Inclusion in this directory is not an endorsement.

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy. (NCT00150423) · Clinical Trials Directory